New York TimesU.S. drug regulators approved the new therapy for adults with aggressive forms of a blood cancer, non-Hodgkin’s lymphoma, who have undergone two regimens of chemotherapy that failed. It was hailed as “another milestone in the development of a whole … …read more Source:: New York City News By Google News
from WordPress http://ift.tt/2xQlglr
via IFTTT
0 comments:
Post a Comment